Showing results (31-40 of 343) with videos related to
Sort By:
Pageof 35
Expert Opinion on Therapeutic Targets|May 17, 2007
Inflammatory bowel diseases: meeting of the European Crohn's Colitis Organization, 1-3 March 2007, Innsbruck, AustriaHerbert TilgDigestive Diseases (Basel, Switzerland)|May 13, 2010
The role of cytokines in non-alcoholic fatty liver diseaseHerbert TilgCurrent Pharmaceutical Design|April 8, 2010
Adipocytokines in nonalcoholic fatty liver disease: key players regulating steatosis, inflammation and fibrosisHerbert TilgEuropean Journal of Gastroenterology & Hepatology|December 3, 2008
Short bowel syndrome: searching for the proper dietHerbert TilgNutrition, Metabolism, and Cardiovascular Diseases : NMCD|February 7, 2021
Apolipoprotein A5 controls fructose-induced metabolic dysregulation in miceClaudia Ress, Jochen Dobner, Kerstin Rufinatscha, et al.Liver International : Official Journal of the International Association for the Study of the Liver|April 20, 2020
Dimethyl fumarate ameliorates hepatic inflammation in alcohol related liver diseaseMoris Sangineto, Felix Grabherr, Timon E Adolph, et al.Scientific Reports|November 13, 2020
Cardioprotective effects of short-term empagliflozin treatment in db/db miceBernhard Radlinger, Florian Hornsteiner, Sabrina Folie, et al.Gut Microbes|July 5, 2022
Recovery of Bacteroides thetaiotaomicron ameliorates hepatic steatosis in experimental alcohol-related liver diseaseMoris Sangineto, Christoph Grander, Felix Grabherr, et al.Expert Opinion on Therapeutic Targets|April 16, 2008
Novel therapeutic targets in the treatment of IBDArthur Kaser, Herbert TilgWiener Medizinische Wochenschrift (1946)|July 12, 2013
[Management of severe alcoholic hepatitis]Verena Wieser, Herbert TilgPageof 35